In early 2026, the success of mRNA platforms in other disease areas is sparking a major push for a new generation of "ultra-stable" mRNA-based polio vaccines. These 2026 research projects aim to create a vaccine that does not require a strict cold chain and can be easily administered via microneedle patches rather than traditional needles and syringes. In early 2026, this "patch" technology is...

"Global Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine   While preparing the first class RNA Therapeutics...

Global Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine   While preparing the first class RNA Therapeutics...

Market Trends Shaping Executive Summary RNA Therapeutics Market Size and Share During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine   RNA Therapeutics Market report performs...

Latest Insights on Executive Summary RNA Therapeutics Market Share and Size During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine   This quality RNA Therapeutics report is structured...